Matt Weichert

Benzinga Q&A: Matt Wiechert of Glaucus Research By now, investors are familiar with the controversies swirling around the Chinese small and mid cap universe. In the last 18 months, a significant number publicly-listed Chinese companies have found themselves the subject of scrutiny by investors...